Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1326 ARTÍCULOS , VIENDO DEL 751 AL 765

11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

Rinne JO, Brooks DJ, Rossor MN, Fox NC, Bullock R, Klunk WE, Mathis CA, Blennow K, Barakos J, Okello AA, Rodriguez Martinez de Liano S, Liu E, Koller M, Gregg KM, Schenk D, Black R, Grundman M.

Lancet Neurol. 2010 Apr;9(4):363-72. doi: 10.1016/S1474-4422(10)70043-0. Epub 2010 Feb 26.

Non-pharmacologic management of sleep disturbance in Alzheimer's disease

David R, Zeitzer J, Friedman L, Noda A, O'Hara R, Robert P, Yesavage JA.

J Nutr Health Aging. 2010 Mar;14(3):203-6. doi: 10.1007/s12603-010-0050-9.

Early detection of Alzheimer's disease with PET imaging

Berti V, Osorio RS, Mosconi L, Li Y, De Santi S, de Leon MJ.

Neurodegener Dis. 2010;7(1-3):131-5. doi: 10.1159/000289222. Epub 2010 Mar 3.

Clinical trial efforts in Alzheimer disease: why test statins?

Arvanitakis Z, Knopman DS.

Neurology. 2010 Mar 23;74(12):945-6. doi: 10.1212/WNL.0b013e3181d6479a. Epub 2010 Mar 3.

Magnetoencephalography in neuropsychiatry: ready for application?

Williams MA, Sachdev PS.

Curr Opin Psychiatry. 2010 May;23(3):273-7. doi: 10.1097/YCO.0b013e328338621d.

Values of default mode network to Alzheimer's disease call for consilience of multimodal neuroimaging and genetics

Hou B, Xu L.

J Neurosci. 2010 Mar 10;30(10):3553-4. doi: 10.1523/JNEUROSCI.6008-09.2010.

Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes

Weintraub D, Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG; DIADS-2 Research Group.

Am J Geriatr Psychiatry. 2010 Apr;18(4):332-40. doi: 10.1097/JGP.0b013e3181cc0333.

The accuracy of short clinical rating scales in neuropathologically diagnosed dementia

Gustafson L, Englund E, Brunnström H, Brun A, Erikson C, Warkentin S, Passant U.

Am J Geriatr Psychiatry. 2010 Sep;18(9):810-20. doi: 10.1097/JGP.0b013e3181cdef7a.

Cholesterol and cognitive performance in normal controls and the influence of elective statin use after conversion to mild cognitive impairment: results in a clinical trial cohort

Sparks DL, Kryscio RJ, Connor DJ, Sabbagh MN, Sparks LM, Lin Y, Liebsack C.

Neurodegener Dis. 2010;7(1-3):183-6. doi: 10.1159/000295660. Epub 2010 Mar 12.

Intravenous immunoglobulins as a treatment for Alzheimer's disease: rationale and current evidence

Dodel R, Neff F, Noelker C, Pul R, Du Y, Bacher M, Oertel W.

Drugs. 2010 Mar 26;70(5):513-28. doi: 10.2165/11533070-000000000-00000.

Apple juice improved behavioral but not cognitive symptoms in moderate-to-late stage Alzheimer's disease in an open-label pilot study

Remington R, Chan A, Lepore A, Kotlya E, Shea TB.

Am J Alzheimers Dis Other Demen. 2010 Jun;25(4):367-71. doi: 10.1177/1533317510363470. Epub 2010 Mar 25.

REVIEW: Apathy diagnosis, assessment, and treatment in Alzheimer's disease

Robert PH, Mulin E, Malléa P, David R.

CNS Neurosci Ther. 2010 Oct;16(5):263-71. doi: 10.1111/j.1755-5949.2009.00132.x.

Long-lasting hemianopia due to PCA

Delaj L, D'Alessandro R, Stracciari A, Fonti C, Cretella L, Lodi R.

J Neurol. 2010 Sep;257(9):1562-4. doi: 10.1007/s00415-010-5540-5. Epub 2010 Mar 30.

Progression of atrophy in Alzheimer's disease and related disorders

Whitwell JL.

Neurotox Res. 2010 Nov;18(3-4):339-46. doi: 10.1007/s12640-010-9175-1. Epub 2010 Mar 30.

Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes

Mosconi L, Berti V, Swerdlow RH, Pupi A, Duara R, de Leon M.

Hum Genomics. 2010 Feb;4(3):170-93. doi: 10.1186/1479-7364-4-3-170.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias